Cargando…
Rapid RT-PCR identification of SARS-CoV-2 in screening donors of fecal microbiota transplantation
Since its first appearance in late 2019 in Wuhan, China, severe acute respiratory syndrome caused by Coronavirus 2 (SARS-CoV-2) has had a major impact on healthcare facilities around the world. Although in the past year, mass vaccination and the development of monoclonal antibody treatments have red...
Autores principales: | Scaglione, Sara, Gotta, Franca, Vay, Daria, Leli, Christian, Roveta, Annalisa, Maconi, Antonio, Rocchetti, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277158/ https://www.ncbi.nlm.nih.gov/pubmed/37366528 http://dx.doi.org/10.1016/j.heliyon.2023.e17438 |
Ejemplares similares
-
Performance of a SARS-CoV-2 antigen rapid immunoassay in patients admitted to the emergency department
por: Leli, Christian, et al.
Publicado: (2021) -
Challenges and costs of donor screening for fecal microbiota transplantations
por: Bénard, Mèlanie V., et al.
Publicado: (2022) -
Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank
por: Seo, Hyun Soo, et al.
Publicado: (2021) -
Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank
por: Seo, Hyun Soo, et al.
Publicado: (2021) -
Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor
por: Bibbò, Stefano, et al.
Publicado: (2020)